Who is eligible for treatment with bimekizumab? Are there any notable exclusion criteria?

Featuring Mark Lebwohl, MD | Senior Clinical Advisor | Professor and Chairman Emeritus of the Kimberly and Eric J. Waldman Department of Dermatology Dean for Clinical Therapeutics at the Icahn School of Medicine, Mount Sinai New York, NY | Published November 06, 2023